Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial

著者: Klaus F. Rabe, Bartolomé R. Celli, Michael E. Wechsler, Raolat M. Abdulai, Xiaodong Luo, Maarten M. Boomsma, Heribert Staudinger, Julie Horowitz, Aris Baras, Manuel A. R. Ferreira, Marcella Ruddy, Michael C. Nivens, Nikhil Amin, David M. Weinreich, George D. Yancopoulos, Hélène Goulaouic - The Lancet 2021 被引用: 206